1. Home
  2. CCCC vs UHG Comparison

CCCC vs UHG Comparison

Compare CCCC & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.74

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Logo United Homes Group Inc

UHG

United Homes Group Inc

HOLD

Current Price

$1.17

Market Cap

68.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
UHG
Founded
2015
N/A
Country
United States
United States
Employees
N/A
175
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
185.1M
68.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CCCC
UHG
Price
$2.74
$1.17
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$12.20
N/A
AVG Volume (30 Days)
2.0M
105.9K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.09
$0.99
52 Week High
$3.82
$4.78

Technical Indicators

Market Signals
Indicator
CCCC
UHG
Relative Strength Index (RSI) 53.50 35.74
Support Level $2.27 $1.16
Resistance Level $2.85 $1.81
Average True Range (ATR) 0.20 0.01
MACD -0.00 0.03
Stochastic Oscillator 63.89 100.00

Price Performance

Historical Comparison
CCCC
UHG

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

About UHG United Homes Group Inc

United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.

Share on Social Networks: